Oragenics Inc (NYSE MKT:OGEN) — Market Cap & Net Worth
Market Cap & Net Worth: Oragenics Inc (OGEN)
Oragenics Inc (NYSE MKT:OGEN) has a market capitalization of $2.42 Million ($2.42 Million) as of July 22, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #29787 globally and #6007 in its home market, demonstrating a 5.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oragenics Inc's stock price $0.60 by its total outstanding shares 4336029 (4.34 Million). Review total liabilities of Oragenics Inc to assess the company's total debt and financial obligations.
Oragenics Inc Market Cap History: 2015 to 2026
Oragenics Inc's market capitalization history from 2015 to 2026. Data shows change from $3.90 Billion to $2.60 Million (-49.55% CAGR).
Oragenics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oragenics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
647.91x
Oragenics Inc's market cap is 647.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $116.03 Million | $86.99K | -$15.71 Million | 1333.90x | N/A |
| 2022 | $27.34 Million | $131.52K | -$14.29 Million | 207.90x | N/A |
| 2023 | $24.40 Million | $37.65K | -$20.66 Million | 647.91x | N/A |
Competitor Companies of OGEN by Market Capitalization
Companies near Oragenics Inc in the global market cap rankings as of July 22, 2026.
Key companies related to Oragenics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #541 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #560 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $480.50 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $672.15 |
| #541 | Argen-X | BR:ARGX | $49.55 Billion | €753.60 |
| #560 | UCB SA | BR:UCB | $47.34 Billion | €238.00 |
Oragenics Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Oragenics Inc's market cap moved from $3.90 Billion to $ 2.60 Million, with a yearly change of -49.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.60 Million | -23.08% |
| 2025 | $3.38 Million | +111.21% |
| 2024 | $1.60 Million | -93.44% |
| 2023 | $24.40 Million | -10.78% |
| 2022 | $27.34 Million | -76.43% |
| 2021 | $116.03 Million | -0.67% |
| 2020 | $116.81 Million | -14.15% |
| 2019 | $136.06 Million | -39.10% |
| 2018 | $223.43 Million | -63.44% |
| 2017 | $611.12 Million | -56.50% |
| 2016 | $1.40 Billion | -64.00% |
| 2015 | $3.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of Oragenics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.42 Million USD |
| MoneyControl | $2.42 Million USD |
| MarketWatch | $2.42 Million USD |
| marketcap.company | $2.42 Million USD |
| Reuters | $2.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oragenics Inc
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation w… Read more